Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 1
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Unknown field was ignored: [Corporate Author]
Page 1
How to interpret and use COVID-19 serology and immunology tests.
Ong DSY, Fragkou PC, Schweitzer VA, Chemaly RF, Moschopoulos CD, Skevaki C; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Ong DSY, et al. Clin Microbiol Infect. 2021 Jul;27(7):981-986. doi: 10.1016/j.cmi.2021.05.001. Epub 2021 May 8. Clin Microbiol Infect. 2021. PMID: 33975005 Free PMC article. Review.
Besides humoral immunity, cellular immunity is also essential for successful host defences against viruses. Enzyme-linked immunospot (ELISpot) assays can be used to measure T-cell responses against SARS-CoV-2. ...
Besides humoral immunity, cellular immunity is also essential for successful host defences against viruses. Enzyme-linked immunospot …
Update of European Society of Clinical Microbiology and Infectious Diseases coronavirus disease 2019 guidelines: diagnostic testing for severe acute respiratory syndrome coronavirus 2.
Fragkou PC, De Angelis G, Menchinelli G, Can F, Garcia F, Morfin-Sherpa F, Dimopoulou D, Dimopoulou K, Zelli S, de Salazar A, Reiter R, Janocha H, Grossi A, Omony J, Skevaki C. Fragkou PC, et al. Clin Microbiol Infect. 2023 Jul;29(7):876-886. doi: 10.1016/j.cmi.2023.04.019. Epub 2023 Apr 22. Clin Microbiol Infect. 2023. PMID: 37088423 Free PMC article.
SCOPE: Since the onset of COVID-19, several assays have been deployed for the diagnosis of SARS-CoV-2. The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) published the first set of guidelines on SARS-CoV …
SCOPE: Since the onset of COVID-19, several assays have been deployed for the diagnosis of SARS-CoV-2. The European Society of …
Epidemiology of respiratory viruses among children during the SARS-CoV-2 pandemic: A systematic review and meta-analysis.
Dallmeyer LK, Schüz ML, Fragkou PC, Omony J, Krumbein H, Dimopoulou D, Dimopoulou K, Skevaki C. Dallmeyer LK, et al. Int J Infect Dis. 2024 Jan;138:10-18. doi: 10.1016/j.ijid.2023.10.023. Epub 2023 Nov 10. Int J Infect Dis. 2024. PMID: 37951460 Free article.
OBJECTIVE: This meta-analysis aimed to assess the prevalence of respiratory viruses among children under the special conditions of the COVID-19 pandemic. ...CONCLUSION: This meta-analysis shows the epidemiology of respiratory viruses other than SARS-Co …
OBJECTIVE: This meta-analysis aimed to assess the prevalence of respiratory viruses among children under the special condition …
Review of trials currently testing treatment and prevention of COVID-19.
Fragkou PC, Belhadi D, Peiffer-Smadja N, Moschopoulos CD, Lescure FX, Janocha H, Karofylakis E, Yazdanpanah Y, Mentré F, Skevaki C, Laouénan C, Tsiodras S; ESCMID Study Group for Respiratory Viruses. Fragkou PC, et al. Clin Microbiol Infect. 2020 Aug;26(8):988-998. doi: 10.1016/j.cmi.2020.05.019. Epub 2020 May 23. Clin Microbiol Infect. 2020. PMID: 32454187 Free PMC article. Review.
Additionally, we evaluated the quality of the retrieved studies. DATA SOURCES: Clinicaltrials.gov, the Chinese Clinical Trial Registry and the European Union Clinical Trials Register were systematically searched. STUDY ELIGIBILITY CRITERIA: Registered …
Additionally, we evaluated the quality of the retrieved studies. DATA SOURCES: Clinicaltrials.gov, the Chinese Clinical Trial Registr …
Autoantibodies are highly prevalent in non-SARS-CoV-2 respiratory infections and critical illness.
Feng A, Yang EY, Moore AR, Dhingra S, Chang SE, Yin X, Pi R, Mack EK, Völkel S, Geßner R, Gündisch M, Neubauer A, Renz H, Tsiodras S, Fragkou PC, Asuni AA, Levitt JE, Wilson JG, Leong M, Lumb JH, Mao R, Pinedo K, Roque J, Richards CM, Stabile M, Swaminathan G, Salagianni ML, Triantafyllia V, Bertrams W, Blish CA, Carette JE, Frankovich J, Meffre E, Nadeau KC, Singh U, Wang TT, Luning Prak ET, Herold S, Andreakos E, Schmeck B, Skevaki C, Rogers AJ, Utz PJ. Feng A, et al. JCI Insight. 2023 Feb 8;8(3):e163150. doi: 10.1172/jci.insight.163150. JCI Insight. 2023. PMID: 36752204 Free PMC article.
Serum samples were screened using Luminex arrays that included 58 cytokines and 55 autoantigens, many of which are associated with connective tissue diseases (CTDs). Samples positive for anti-cytokine antibodies were tested for receptor blocking activity using cell-based f …
Serum samples were screened using Luminex arrays that included 58 cytokines and 55 autoantigens, many of which are associated with connectiv …
Host immune responses and possible therapeutic targets for viral respiratory tract infections in susceptible populations: a narrative review.
Fragkou PC, Moschopoulos CD, Reiter R, Berger T, Skevaki C; ESCMID Study Group for Respiratory Viruses (ESGREV). Fragkou PC, et al. Clin Microbiol Infect. 2022 Oct;28(10):1328-1334. doi: 10.1016/j.cmi.2022.03.010. Epub 2022 Mar 17. Clin Microbiol Infect. 2022. PMID: 35307574 Free article. Review.
BACKGROUND: Respiratory viruses are associated with significant global morbidity and mortality, as well as socioeconomic factors. Certain conditions and patient groups are more susceptible to develop severe viral respiratory tract infections (RTIs). OBJECTIVE …
BACKGROUND: Respiratory viruses are associated with significant global morbidity and mortality, as well as socioeconomic facto …
Global prevalence of respiratory virus infections in adults and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis.
Schüz ML, Dallmeyer L, Fragkou PC, Omony J, Krumbein H, Hünerbein BL, Skevaki C. Schüz ML, et al. Int J Infect Dis. 2023 Dec;137:16-24. doi: 10.1016/j.ijid.2023.10.001. Epub 2023 Oct 6. Int J Infect Dis. 2023. PMID: 37806653 Free article.
OBJECTIVES: Since the beginning of the COVID-19 pandemic, efforts have been made to contain the spread of the virus. However, the epidemiological burden of other respiratory viruses during the pandemic is unclear. We aim to address the epidemiology of respiratory …
OBJECTIVES: Since the beginning of the COVID-19 pandemic, efforts have been made to contain the spread of the virus. However, the epidemiolo …
Clinical trials for treatment of respiratory viral infections in recipients of haematopoietic cell transplantation and cellular therapies: are we on the right path to the finish line?
Sassine J, Hirsch HH, Chemaly RF; European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Sassine J, et al. Clin Microbiol Infect. 2024 Mar;30(3):270-275. doi: 10.1016/j.cmi.2023.09.013. Epub 2023 Sep 22. Clin Microbiol Infect. 2024. PMID: 37742829 No abstract available.
An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab.
Shafat T, Grupel D, Porges T, Abuhasira R, Belkin A, Deri O, Oster Y, Zahran S, Horwitz E, Horowitz NA, Khatib H, Batista MV, Cortez AC, Brosh-Nissimov T, Segman Y, Ishay L, Cohen R, Atamna A, Spallone A, Chemaly RF, Ramos-Ramos JC, Chowers M, Rogozin E, Oren NC, Keske Ş, Barchad OW, Nesher L; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Shafat T, et al. Cancer Med. 2024 Feb;13(3):e6997. doi: 10.1002/cam4.6997. Cancer Med. 2024. PMID: 38400683 Free PMC article.
OBJECTIVES: Hematological malignancy (HM) patients treated with anti-CD20 monoclonal antibodies are at higher risk for severe COVID-19. A previous single-center study showed worse outcomes in patients treated with obinutuzumab compared to rituximab. ...Our findings undersc …
OBJECTIVES: Hematological malignancy (HM) patients treated with anti-CD20 monoclonal antibodies are at higher risk for severe COVID-19. A pr …
11 results